April 6, 2017 / 9:07 PM / 8 months ago

BRIEF-Marinus Pharma signs supply agreement with Cydex Pharma

April 6 (Reuters) - Cydex Pharmaceuticals Inc

* Marinus Pharmaceuticals Inc - on march 31, 2017, entered into a license agreement and a supply agreement with Cydex Pharmaceuticals Inc - sec filing

* Marinus Pharmaceuticals Inc-under terms of supply agreement, co required to purchase all of requirements for Captisol with respect to Ganaxolone from Cydex

* Marinus Pharmaceuticals Inc- Cydex granted co exclusive license to use Cydex Captisol drug formulation system, related intellectual property

* Marinus Pharmaceuticals Inc-under terms of supply agreement, Cydex is required to supply co with Captisol for such purposes, subject to certain limitations

* Marinus Pharmaceuticals Inc-as consideration for license,co paid upfront fee, required to make additional payments on achievement of specified milestones

* Marinus Pharmaceuticals Inc- will be required to pay royalties to Cydex on sales of Ganaxolone in low-to-mid single digits based on levels of annual net sales Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below